Updates on HPV vaccination

The anti-HPV vaccine is the second vaccine for the prevention of some types of cancer, made on the basis of VLP (virus-like particle) technology. Since its appearance, it has proven effectiveness in conditions of excellent safety. This review aims at clarifying some important aspects, based on the evidence accumulated in recent years, such as the vaccines available, the number of doses, and the vaccination of particular categories – immunocompromised patients, vaccination after LEEP excisions, or vaccination in old patients.